Teva Pharmaceutical Industries Ltd (TEVJF) Depreciation and Depletion (2025 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Depreciation and Depletion came in at $36.0 million in Q2 2026, down 2.7% YoY from $37.0 million in Q2 2025, and little changed on a QoQ basis from $36.0 million in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Depreciation and Depletion (2025 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 2 years of Depreciation and Depletion data on file, last reported at $36.0 million in Q2 2026.
- Quarterly Depreciation and Depletion fell 2.7% year-over-year to $36.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $145.0 million (changed N/A YoY) and the FY2025 annual result came in at $421.0 million, down 10.62% from the prior year.
- Depreciation and Depletion steadied at $36.0 million in Q2 2026, from $36.0 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $37.0 million in Q2 2025 to a low of $36.0 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.00 Mn |
| Jun 30, 2026 | 36.00 Mn |
| Mar 31, 2026 | 36.00 Mn |
| Mar 31, 2026 | 36.00 Mn |
| Jun 30, 2025 | 37.00 Mn |
| Jun 30, 2025 | 37.00 Mn |
| Mar 31, 2025 | 36.00 Mn |
| Mar 31, 2025 | 36.00 Mn |